Allison Vitsky

799 total citations
27 papers, 540 citations indexed

About

Allison Vitsky is a scholar working on Immunology, Small Animals and Molecular Biology. According to data from OpenAlex, Allison Vitsky has authored 27 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Small Animals and 7 papers in Molecular Biology. Recurrent topics in Allison Vitsky's work include Animal testing and alternatives (6 papers), Immunotoxicology and immune responses (4 papers) and Immune Cell Function and Interaction (3 papers). Allison Vitsky is often cited by papers focused on Animal testing and alternatives (6 papers), Immunotoxicology and immune responses (4 papers) and Immune Cell Function and Interaction (3 papers). Allison Vitsky collaborates with scholars based in United States, Canada and Germany. Allison Vitsky's co-authors include Nasir Khan, Sherry J. Morgan, Evan B. Janovitz, Tanja S. Zabka, Chandikumar S. Elangbam, Shawn Berens, Janet K. Yamamoto, Ruiyu Pu, Tim Nichols and Bernard S. Buetow and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Allison Vitsky

25 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison Vitsky United States 14 170 134 129 63 55 27 540
Kathleen S. Cormier United States 6 140 0.8× 140 1.0× 108 0.8× 40 0.6× 24 0.4× 7 452
Chakib Boussahmain United States 7 139 0.8× 64 0.5× 127 1.0× 23 0.4× 20 0.4× 8 364
Chi‐Tan Hu Taiwan 18 303 1.8× 92 0.7× 79 0.6× 58 0.9× 32 0.6× 48 823
Leslie Obert United States 15 121 0.7× 123 0.9× 165 1.3× 19 0.3× 62 1.1× 29 770
Anouk L. Feitsma Netherlands 13 245 1.4× 185 1.4× 51 0.4× 19 0.3× 30 0.5× 19 840
Michael Kammüller Switzerland 20 108 0.6× 453 3.4× 73 0.6× 89 1.4× 62 1.1× 43 772
Christine Koch Germany 15 231 1.4× 55 0.4× 363 2.8× 115 1.8× 21 0.4× 58 803
Paul Kearney United States 13 176 1.0× 72 0.5× 79 0.6× 51 0.8× 45 0.8× 25 578
Amy Usborne United States 10 81 0.5× 45 0.3× 72 0.6× 20 0.3× 33 0.6× 13 404
Michihide Uo Japan 5 216 1.3× 112 0.8× 109 0.8× 13 0.2× 43 0.8× 6 496

Countries citing papers authored by Allison Vitsky

Since Specialization
Citations

This map shows the geographic impact of Allison Vitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Vitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Vitsky more than expected).

Fields of papers citing papers by Allison Vitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Vitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Vitsky. The network helps show where Allison Vitsky may publish in the future.

Co-authorship network of co-authors of Allison Vitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Vitsky. A scholar is included among the top collaborators of Allison Vitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Vitsky. Allison Vitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guha, Mausumee, Stéphane Thibault, Son M. Pham, et al.. (2024). Nonclinical Profile of PF-06952229 (MDV6058), a Novel TGFβRI/Activin Like Kinase 5 Inhibitor Supports Clinical Evaluation in Cancer. Journal of Pharmacology and Experimental Therapeutics. 391(2). 335–345. 1 indexed citations
2.
Ji, Changhua, Bing Kuang, Bernard S. Buetow, et al.. (2024). Pharmacokinetics, pharmacodynamics, and toxicity of a PD-1-targeted IL-15 in cynomolgus monkeys. PLoS ONE. 19(2). e0298240–e0298240. 3 indexed citations
3.
Sathish, Jean G., Declan Flynn, Stephen Jenkinson, et al.. (2022). Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™. International Journal of Toxicology. 41(4). 276–290. 13 indexed citations
4.
Vitsky, Allison, Aida Sacaan, Wenyue Hu, Martin B. Finkelstein, & William J. Reagan. (2022). Gemtuzumab Ozogamicin Treatment Results in Decreased Proliferation and Differentiation of Human Megakaryocytes but Does Not Inhibit Mature Platelet Function. Toxicologic Pathology. 50(7). 871–880.
5.
Reagan, William J., Marjory B. Brooks, Renata Grozovsky, et al.. (2022). To Clot or Not to Clot: Deepening Our Understanding of Alterations in the Hemostatic System. Toxicologic Pathology. 50(7). 890–894.
6.
Keck, James, Wenqian He, Bernard S. Buetow, et al.. (2022). Validation of a clinically relevant humanized mouse model for the safety assessment of 4-1BB agonists utomilumab and urelumab.. Journal of Clinical Oncology. 40(16_suppl). e14602–e14602. 2 indexed citations
7.
Ji, Changhua, Marc D. Roy, Jonathan Golas, et al.. (2019). Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors. Clinical Cancer Research. 25(15). 4735–4748. 91 indexed citations
8.
Peng, Qinghai, Ahmed Shoieb, Ingrid D. Pardo, et al.. (2019). Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice. PLoS ONE. 14(1). e0210995–e0210995. 23 indexed citations
9.
Ramaiah, Lila, Lindsay Tomlinson, Niraj Tripathi, et al.. (2017). Principles for Assessing Adversity in Toxicologic Clinical Pathology. Toxicologic Pathology. 45(2). 260–266. 14 indexed citations
10.
Sacaan, Aida, Stéphane Thibault, Tim Nichols, et al.. (2017). CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats. Molecular Cancer Research. 15(11). 1531–1541. 17 indexed citations
11.
12.
Heyen, Jonathan R., Jennifer L. Rojko, Mark G. Evans, et al.. (2014). Characterization, Biomarkers, and Reversibility of a Monoclonal Antibody-induced Immune Complex Disease in Cynomolgus Monkeys (Macaca fascicularis). Toxicologic Pathology. 42(4). 765–773. 22 indexed citations
13.
Vitsky, Allison, et al.. (2014). Post mortem histological artifacts created by poor tissue handling during necropsy. Journal of Histotechnology. 37(2). 43–47. 1 indexed citations
14.
Yanochko, Gina M., Allison Vitsky, Jonathan R. Heyen, et al.. (2013). Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction. Toxicological Sciences. 135(2). 451–464. 58 indexed citations
15.
Morgan, Sherry J., Chandikumar S. Elangbam, Shawn Berens, et al.. (2012). Use of Animal Models of Human Disease for Nonclinical Safety Assessment of Novel Pharmaceuticals. Toxicologic Pathology. 41(3). 508–518. 59 indexed citations
16.
Vitsky, Allison, Robert Pawliuk, Michael L. Hawes, et al.. (2009). Homeostatic Role of Transforming Growth Factor-β in the Oral Cavity and Esophagus of Mice and Its Expression by Mast Cells in These Tissues. American Journal Of Pathology. 174(6). 2137–2149. 23 indexed citations
17.
Woodworth, Lisa, et al.. (2008). Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-β1 in the MRL/lpr lupus mouse model. Lupus. 17(9). 822–831. 15 indexed citations
18.
García, Alexis, Robert P. Marini, Yan Feng, et al.. (2002). A Naturally Occurring Rabbit Model of EnterohemorrhagicEscherichia coli–Induced Disease. The Journal of Infectious Diseases. 186(11). 1682–1686. 29 indexed citations
19.
McGuire, Nancy, et al.. (2002). Pulmonary Thromboembolism Associated With Blastomyces dermatitidis in a Dog. Journal of the American Animal Hospital Association. 38(5). 425–430. 9 indexed citations
20.
Pu, Ruiyu, et al.. (1998). Efficacy evaluation of prime–boost protocol. AIDS. 12(1). 11–18. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen S. Cormier Breakdown of academic impact, for papers by Chakib Boussahmain Breakdown of academic impact, for papers by Chi‐Tan Hu Breakdown of academic impact, for papers by Leslie Obert Breakdown of academic impact, for papers by Anouk L. Feitsma Breakdown of academic impact, for papers by Michael Kammüller Breakdown of academic impact, for papers by Christine Koch Breakdown of academic impact, for papers by Paul Kearney Breakdown of academic impact, for papers by Amy Usborne Breakdown of academic impact, for papers by Michihide Uo
Rankless by CCL
2026